About Us

Alternative content for the map

About Bharat Biotech:

Bharat Biotech is a pioneering biotechnology company known for its world-class R&D and manufacturing capabilities. Our mission is to deliver affordable, safe and high-quality vaccines and bio-therapeutics that help people prevail over diseases. We seek to lead innovation in biotechnology in order to lead the fight against disease with a focus on emerging markets.

Our competition isn't with the competitors its with the diseases

Dr. Krishna Ella

67
Countries
380
Patents
96
Scientists
7
Billion Smiles

Timeline

Dr. Krishna M. Ella & Mrs. Suchitra Ella founded Bharat Biotech in Genome Valley, Hyderabad, India.
Dr. A.P.J Abdul Kalam launches Hepatitis B Vaccine – Revac-B+®; Bharat Biotech pioneers the World’s First Cesium Chloride Free Hepatitis B vaccine.
The Company expands facility, to make 100 million doses of Hepatitis B vaccine (Revac-B) annually, from eight million doses – to become the largest manufacturers of Hepatitis B vaccines in the world.
Chandrababu Naidu, former CM launches India’s first Probiotic Yeast – BIOGIT®, and Bharat Biotech’s first Bio-therapeutic product.
Bharat Biotech, the first Indian Company to receive two grants from the Bill & Melinda Gates Foundation through PATH to develop new vaccines against Malaria and Rotavirus.
Father of Polysaccharide Vaccines, Dr. John B. Robbins was felicitated by Bharat Biotech for his tremendous contribution to the world of vaccines.
Bharat Biotech pioneers India’s First Recombinant Human Epidermal Growth Factors for I & II degree burns, skin grafts, and diabetic foot ulcers – REGEN-D®. And simultaneously launched it’s 2nd Biotherapeutic product, ZELECT® – Oral Rehydration Salts.
The Company announces a manufacturing and marketing agreement with Cambridge-based Acambis, plc., for developing Japanese Encephalitis vaccine – a neglected disease.
Dr Julie Gerberding, Director, Centre for Disease Control and Prevention (CDC) launched the chromatographically purified vero cell rabies vaccine, INDIRAB® (then Rabirix®).
The Company launches BioHib®, India’s first indigenously developed and manufactured Haemophilus Influenza type B (Hib) vaccine
Dr. Manmohan Singh, Hon’ble Prime Minister of India presents FICCI Award by the Federation of Indian Chambers of Commerce and Industry for “Excellence in Science, Technology and Technological Innovation”.
Comvac 5 PFS® (Pre-Filled Syringes) – Pentavalent Combination vaccine – Bharat Biotech’s best-selling product was launched by Senior General Mr. Than Shwe, Chairman, State Peace & Development Council, Union of Myanmar.
Bharat Biotech launched HNVAC® – India’s first cell culture-based H1N1 (Human Inactivated Influenza A virus) Swine flu Vaccine.
Bill Gates, co-chair of the Bill & Melinda Gates Foundation and Chairman of Microsoft, meets Dr. Krishna Ella, CMD of Bharat Biotech, regarding developement of RotavacTM – Bharat Biotech’s affordable diarrheal vaccine.
Bharat Biotech & University of Maryland collaboratively received USD 4 Million ‘Strategic Translation Award’ from the Wellcome Trust for clinical development of a new life-saving conjugate vaccine for Invasive Non-Typhoidal Salmonella (iNTS).
The Company launches Typabar TCV®. – is the world’s 1st clinically proven conjugate Typhoid vaccine.
The Company launches JENVAC®- is safe and highly effective vaccine that protects against all the known strains of Japanese encephalitis.
Lorem Ipsum
Lorem Ipsum
Lorem Ipsum